PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 78 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,563 | +213.7% | 6,250 | +212.5% | 0.00% | – |
| Q2 2023 | $10,061 | -34.6% | 2,000 | -20.0% | 0.00% | – |
| Q1 2023 | $15,376 | +18.3% | 2,500 | +149.5% | 0.00% | – |
| Q4 2022 | $13,000 | +333.3% | 1,002 | +0.2% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 1,000 | -1.1% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 1,011 | -10.6% | 0.00% | – |
| Q1 2022 | $7,000 | -36.4% | 1,131 | -18.1% | 0.00% | – |
| Q4 2021 | $11,000 | -56.0% | 1,381 | -15.3% | 0.00% | – |
| Q3 2021 | $25,000 | -21.9% | 1,631 | -35.0% | 0.00% | – |
| Q2 2021 | $32,000 | +357.1% | 2,511 | +66.2% | 0.00% | – |
| Q1 2021 | $7,000 | +250.0% | 1,511 | +86.3% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 811 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 811 | +7272.7% | 0.00% | – |
| Q2 2020 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |